Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Marshfield, Wisconsin
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Weston, Wisconsin
- Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Location: Weston, Wisconsin
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke
Conditions: Leukemia
Location: Marshfield, Wisconsin
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke
Conditions: Leukemia
Location: Stevens Point, Wisconsin
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke
Conditions: Leukemia
Location: Wausau, Wisconsin
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke
Conditions: Leukemia
Location: Wausau, Wisconsin
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke
Conditions: Leukemia
Location: Weston, Wisconsin
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke
Conditions: Leukemia
Location: Wisconsin Rapids, Wisconsin
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Conditions: Sarcoma
Location: Marshfield, Wisconsin
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Wausau, Wisconsin
- Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastom
Conditions: Brain and Central Nervous System Tumors
Location: Marshfield, Wisconsin
- Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For
Conditions: Nausea and Vomiting - Unspecified Adult Solid Tumor, Protocol Specific
Location: Marshfield, Wisconsin
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Marshfield, Wisconsin
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Marshfield, Wisconsin
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Stevens Point, Wisconsin
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Stevens Point, Wisconsin
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Weston, Wisconsin
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Weston, Wisconsin
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Wisconsin Rapids, Wisconsin
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Wausau, Wisconsin
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Wisconsin Rapids, Wisconsin
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Marshfield, Wisconsin
- Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sar
Conditions: Sarcoma
Location: Marshfield, Wisconsin
- Insulin Resistance Intervention After Stroke Trial
Conditions: Stroke - Myocardial Infarction - Diabetes
Location: Marshfield, Wisconsin
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Conditions: Sarcoma
Location: Marshfield, Wisconsin
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Marshfield, Wisconsin
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Marshfield, Wisconsin
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Stevens Point, Wisconsin
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Stevens Point, Wisconsin
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Wausau, Wisconsin
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Weston, Wisconsin
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Weston, Wisconsin
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Wisconsin Rapids, Wisconsin
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Conditions: Kidney Cancer
Location: Marshfield, Wisconsin
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroect
Conditions: Brain and Central Nervous System Tumors
Location: Marshfield, Wisconsin
- Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surge
Conditions: Kidney Cancer
Location: Marshfield, Wisconsin
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Conditions: Sarcoma
Location: Marshfield, Wisconsin
- Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Marshfield, Wisconsin
- Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Marshfield, Wisconsin
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
Location: Marshfield, Wisconsin
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
Location: Stevens Point, Wisconsin
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
Location: Wausau, Wisconsin
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
Location: Wausau, Wisconsin
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
Location: Weston, Wisconsin
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
Location: Wisconsin Rapids, Wisconsin
- A Randomized Trial of Unruptured Brain AVMs
Conditions: Unruptured Brain Arteriovenous Malformation
Location: Marshfield, Wisconsin
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: Marshfield, Wisconsin
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Wausau, Wisconsin
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Marshfield, Wisconsin
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Marshfield, Wisconsin
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Stevens Point, Wisconsin
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Wausau, Wisconsin
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Weston, Wisconsin
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Wisconsin Rapids, Wisconsin
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Wisconsin Rapids, Wisconsin
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Marshfield, Wisconsin
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Marshfield, Wisconsin
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Stevens Point, Wisconsin
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Stevens Point, Wisconsin
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Weston, Wisconsin
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Wisconsin Rapids, Wisconsin
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Marshfield, Wisconsin
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Stevens Point, Wisconsin
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Stevens Point, Wisconsin
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Wausau, Wisconsin
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Weston, Wisconsin
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Wisconsin Rapids, Wisconsin
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Wisconsin Rapids, Wisconsin
- Evaluating the Effectiveness of the LifeVest Defibrillator and Improving Methods for Determining the Use of Implantable Cardioverter Defibrillators
Conditions: Death, Sudden, Cardiac - Myocardial Infarction - Arrhythmias, Cardiac
Location: Marshfield, Wisconsin
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Marshfield, Wisconsin
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Stevens Point, Wisconsin
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Stevens Point, Wisconsin
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Weston, Wisconsin
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Weston, Wisconsin
- Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
Conditions: Leukemia
Location: Marshfield, Wisconsin
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Wisconsin Rapids, Wisconsin
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Marshfield, Wisconsin
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Marshfield, Wisconsin
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Stevens Point, Wisconsin
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Weston, Wisconsin
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Wisconsin Rapids, Wisconsin
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Marshfield, Wisconsin
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Marshfield, Wisconsin
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Stevens Point, Wisconsin
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Stevens Point, Wisconsin
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Wausau, Wisconsin
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Weston, Wisconsin
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Wisconsin Rapids, Wisconsin
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Marshfield, Wisconsin
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Marshfield, Wisconsin
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Stevens Point, Wisconsin
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Wausau, Wisconsin
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Weston, Wisconsin
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Wisconsin Rapids, Wisconsin
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Wisconsin Rapids, Wisconsin
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Marshfield, Wisconsin
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Marshfield, Wisconsin
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Marshfield, Wisconsin
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Marshfield, Wisconsin
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Stevens Point, Wisconsin
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Wausau, Wisconsin
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Weston, Wisconsin
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Weston, Wisconsin
- Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Marshfield, Wisconsin
- Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Stevens Point, Wisconsin
- Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Weston, Wisconsin
- Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Wisconsin Rapids, Wisconsin
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Marshfield, Wisconsin
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Marshfield, Wisconsin
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Stevens Point, Wisconsin
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Stevens Point, Wisconsin
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Wausau, Wisconsin
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Weston, Wisconsin
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Weston, Wisconsin
- Collecting Tumor Samples From Patients With Gynecological Tumors
Conditions: Cancer
Location: Wisconsin Rapids, Wisconsin
- Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
Conditions: Kidney Cancer - Nonneoplastic Condition
Location: Marshfield, Wisconsin
- Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
Location: Marshfield, Wisconsin
- Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
Location: Wisconsin Rapids, Wisconsin
- Home-Based Programs for Improving Sleep in Cancer Survivors
Conditions: Cancer Survivor - Fatigue - Psychosocial Effects of Cancer and Its Treatment - Sleep Disorders
Location: Marshfield, Wisconsin
- Home-Based Programs for Improving Sleep in Cancer Survivors
Conditions: Cancer Survivor - Fatigue - Psychosocial Effects of Cancer and Its Treatment - Sleep Disorders
Location: Stevens Point, Wisconsin
- Home-Based Programs for Improving Sleep in Cancer Survivors
Conditions: Cancer Survivor - Fatigue - Psychosocial Effects of Cancer and Its Treatment - Sleep Disorders
Location: Weston, Wisconsin
- Home-Based Programs for Improving Sleep in Cancer Survivors
Conditions: Cancer Survivor - Fatigue - Psychosocial Effects of Cancer and Its Treatment - Sleep Disorders
Location: Wisconsin Rapids, Wisconsin
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Marshfield, Wisconsin
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Stevens Point, Wisconsin
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Weston, Wisconsin
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Weston, Wisconsin
- Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Wisconsin Rapids, Wisconsin
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Marshfield, Wisconsin
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Stevens Point, Wisconsin
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Weston, Wisconsin
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Wisconsin Rapids, Wisconsin
- Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Canc
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
Location: Wausau, Wisconsin
- Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Canc
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
Location: Wisconsin Rapids, Wisconsin
- ABLATE AF Registry Trial
Conditions: Atrial Fibrillation
Location: Wausau, Wisconsin
- Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
Conditions: Non-Hodgkins Lymphoma
Location: Marshfield, Wisconsin
- Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
Conditions: Non-Hodgkins Lymphoma
Location: Wausau, Wisconsin
- Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neurob
Conditions: Neuroblastoma
Location: Marshfield, Wisconsin
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Marshfield, Wisconsin
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Stevens Point, Wisconsin
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Weston, Wisconsin
- Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)
Conditions: Parkinson's Disease
Location: Marshfield, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Marshfield, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Marshfield, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Stevens Point, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Stevens Point, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Wausau, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Weston, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Weston, Wisconsin
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Wisconsin Rapids, Wisconsin
- Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
Conditions: Anal Cancer
Location: Marshfield, Wisconsin
- Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
Conditions: Anal Cancer
Location: Stevens Point, Wisconsin
- Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
Conditions: Anal Cancer
Location: Wausau, Wisconsin
- Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
Conditions: Anal Cancer
Location: Weston, Wisconsin
- Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
Conditions: Anal Cancer
Location: Wisconsin Rapids, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Marshfield, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Marshfield, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Stevens Point, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Stevens Point, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Wausau, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Weston, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Wisconsin Rapids, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Wisconsin Rapids, Wisconsin
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Marshfield, Wisconsin
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Wausau, Wisconsin
- Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms Tumor
Conditions: Kidney Cancer - Metastatic Cancer
Location: Marshfield, Wisconsin
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Marshfield, Wisconsin
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial
Conditions: Brain and Central Nervous System Tumors
Location: Marshfield, Wisconsin
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Marshfield, Wisconsin
- Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
Conditions: Ototoxicity - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Marshfield, Wisconsin
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Marshfield, Wisconsin
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Thera
Conditions: Prostate Cancer
Location: Wisconsin Rapids, Wisconsin
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Marshfield, Wisconsin
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Stevens Point, Wisconsin
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Stevens Point, Wisconsin
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Weston, Wisconsin
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Wisconsin Rapids, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Marshfield, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Stevens Point, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Stevens Point, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Wausau, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Weston, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Wisconsin Rapids, Wisconsin
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Wisconsin Rapids, Wisconsin
- Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Conditions: Lung Cancer
Location: Wausau, Wisconsin
- Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid
Conditions: Brain and Central Nervous System Tumors
Location: Marshfield, Wisconsin
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
Location: Wausau, Wisconsin
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm - Carcinoma Non-small Cell Lung Cancer Stage IIIA - Carcinoma Non-small Cell Lung Cancer Stage IIIB - Carcinoma Non-small Cell Lung Cancer Stage IV
Location: Weston, Wisconsin
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblasto
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Liver Cancer - Neuroblastoma - Ototoxicity - Ovarian Cancer - Sarcoma
Location: Marshfield, Wisconsin
- Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337 AM4/AM5)
Conditions: Hypertension
Location: Marshfield, Wisconsin
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Marshfield, Wisconsin
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Marshfield, Wisconsin
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Stevens Point, Wisconsin
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Wausau, Wisconsin
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Weston, Wisconsin
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Wisconsin Rapids, Wisconsin
- Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)
Conditions: Brain and Central Nervous System Tumors - Chemotherapeutic Agent Toxicity - Cognitive/Functional Effects - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment - Radiation Toxicity - Therapy-related Toxicity
Location: Marshfield, Wisconsin
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Marshfield, Wisconsin
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Marshfield, Wisconsin
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Stevens Point, Wisconsin
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Stevens Point, Wisconsin
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Weston, Wisconsin
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Weston, Wisconsin
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Weston, Wisconsin
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Wisconsin Rapids, Wisconsin
- An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Ca
Conditions: Breast Cancer
Location: Wausau, Wisconsin
- Clarification of Optimal Anticoagulation Through Genetics
Conditions: Stroke - Venous Thrombosis - Atrial Fibrillation - Atrial Flutter
Location: Marshfield, Wisconsin
- Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
Conditions: Coronary Artery Disease - Mitral Valve Regurgitation - Mitral Valve Incompetence - Heart Failure
Location: Wausau, Wisconsin
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Marshfield, Wisconsin
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Marshfield, Wisconsin
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Marshfield, Wisconsin
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Marshfield, Wisconsin
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Stevens Point, Wisconsin
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Wausau, Wisconsin
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Weston, Wisconsin
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Weston, Wisconsin
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Wisconsin Rapids, Wisconsin
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Marshfield, Wisconsin
- Study of Kidney Tumors in Young Patients
Conditions: Kidney Cancer - Nonneoplastic Condition
Location: Marshfield, Wisconsin
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Marshfield, Wisconsin
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Marshfield, Wisconsin
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Stevens Point, Wisconsin
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Stevens Point, Wisconsin
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Wausau, Wisconsin
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Weston, Wisconsin
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Wisconsin Rapids, Wisconsin
- Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
Conditions: Sarcoma
Location: Marshfield, Wisconsin
- Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
Conditions: Sarcoma
Location: Marshfield, Wisconsin
- Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Marshfield, Wisconsin
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Conditions: Neuroblastoma
Location: Marshfield, Wisconsin
- Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Conditions: Atrial Fibrillation - Arrhythmia - Stroke Prevention - Mortality
Location: Marshfield, Wisconsin
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Conditions: Chordoma - Desmoid Tumor - Sarcoma
Location: Marshfield, Wisconsin
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Conditions: Brain and Central Nervous System Tumors
Location: Marshfield, Wisconsin
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Marshfield, Wisconsin
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Marshfield, Wisconsin
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Stevens Point, Wisconsin
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Stevens Point, Wisconsin
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Wausau, Wisconsin
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Weston, Wisconsin
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Weston, Wisconsin
- Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Wausau, Wisconsin
- Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Marshfield, Wisconsin
- Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Stevens Point, Wisconsin
- Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Wausau, Wisconsin
- Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Weston, Wisconsin
- Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Wisconsin Rapids, Wisconsin
- Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer - Psychosocial Effects of Cancer and Its Treatment
Location: Marshfield, Wisconsin
- Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer - Psychosocial Effects of Cancer and Its Treatment
Location: Weston, Wisconsin
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: Marshfield, Wisconsin
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: Marshfield, Wisconsin
|